Q2 2025 Results Conference Call May 8, 2025 8:00 AM ETCompany ParticipantsSam Fisch - Executive Director, Investor Relations ...

FOR years stay-at-home mum Natalie Strange tried everything to lose weight – all the trendy diets, calorie counting, you name ...

Understand how semaglutide shows strong benefits in MASH treatment, improving liver health and reducing weight.

A new generation of GLP-1 drugs promising fast results continues to rock the weight loss industry, which has emphasized ...

With more and more people signing up for weight loss drugs, the potential side effects are starting to attract attention.

Hims & Hers Health, Inc.'s Q1 results show 111% growth, yet shares fell 8%. Click for a look at the impact of drug access, ...

Data across obesity, cardiovascular disease, MASH, type 2 diabetes, as well as advances in obesity-related care to be presented at ECO 2025 - covering burden, and the value of treatment and prevention ...

Last year, more than 16 million people googled 'semaglutide' - sold under the brand names Wegovy and Ozempic - as demand for ...

WHEN Chanel Robinson piled on the pounds in the pandemic her self esteem took a hit – but that wasn’t the only downside.

Semaglutide - the active ingredient in medications like Ozempic and WeGovy - is only FDA approved for Type-2 diabetes, but ...

Though popular weight loss jabs like Ozempic and Wegovy have been deemed safe and effective by the FDA, concerning side ...

Weight-loss drugs like Ozempic and Wegovy are sending dozens of Americans to the hospital every day with potentially ...